OneMedNet Integrates Palantir Foundry, Bolsters Real-World Data Network

Event summary

  • OneMedNet’s iRWD™ Platform, built on Palantir Foundry, is now live, providing searchable access to billions of records across 80 million patient journeys.
  • The network has grown ~70% to 80 million patients and 251 million studies.
  • The platform provides access to approximately 47 million tokenized patients via Datavant.
  • Two new customers have contracted for the iRWD™ Platform.

The big picture

OneMedNet’s integration of Palantir Foundry and Datavant represents a significant push in the burgeoning real-world data market, which is increasingly vital for AI model development and drug discovery. The company’s strategy of combining curated data with tokenized patient linkage aims to create a durable competitive advantage, but the success hinges on converting interest into consistent, high-margin subscriptions and navigating the complex regulatory landscape surrounding patient data.

What we're watching

Subscription Adoption
The ability to convert the growing customer pipeline into meaningful annual recurring revenue will be a key indicator of the platform’s success and OneMedNet’s overall financial performance.
Data Security
How OneMedNet manages the security and privacy of the vast, tokenized patient data pool will be critical to maintaining trust with customers and avoiding regulatory scrutiny.
Competitive Landscape
The emergence of other large-scale, AI-driven RWD platforms could erode OneMedNet’s competitive advantage and necessitate ongoing innovation to maintain market share.

Related topics

Technology